bioAffinity Technologies
BIAF
12 hedge funds and large institutions have $824K invested in bioAffinity Technologies in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 0 reducing their positions, and 9 closing their positions.
3,366% more capital inflows, than outflows
Capital inflows: $2.37M | Capital outflows: $68.4K
4.39% more ownership
Funds ownership: 2.32% → 6.71% (+4.4%)
14% less funds holding
Funds holding: 14 → 12 (-2)
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$1.93M |
| 2 |
IFP Advisors
Tampa,
Florida
|
+$199K |
| 3 |
Scientech Research LLC
Jersey City,
New Jersey
|
+$132K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$72.2K |
| 5 |
Tower Research Capital (TRC)
New York
|
+$19.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
-$36K |
| 2 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$8.01K |
| 3 |
State Street
Boston,
Massachusetts
|
-$5.06K |
| 4 |
XTX Topco
George Town,
Cayman Islands
|
-$4.48K |
| 5 |
StoneX Group
New York
|
-$4.37K |
BIAF Hedge Fund Activity: Q3 2025 in Review
12 of the 7,657 institutional investors tracked by Wall St. Rank reported a position in bioAffinity Technologies (BIAF) for Q3 2025, worth a combined $824K — up 692% from $104K a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of BIAF and 7 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 4 added.
The largest buyer was Sabby Management, opening a new position worth an estimated $1.93M. The largest seller was Geode Capital Management, exiting entirely with an estimated $36K sold.
- 12 institutional investors held bioAffinity Technologies (BIAF) as of Q3 2025, down from 14 in Q2 2025.
- Funds reported $824K of bioAffinity Technologies stock for Q3 2025, up 692% quarter-over-quarter.
- 7 funds opened new bioAffinity Technologies positions in Q3 2025 and 9 closed out, a net change of -2 holders.
- The largest bioAffinity Technologies buyer in Q3 2025 was Sabby Management, an estimated $1.93M added.
- The largest bioAffinity Technologies seller in Q3 2025 was Geode Capital Management, an estimated $36K sold.
Based on aggregated 13F filings for Q3 2025.